FI62838C - Foerfarande foer framstaellning av den nya farmaceutiskt anvaendbara hoegerroterande isomeren av en asymmetriskt spiro-hydantoinfoerening - Google Patents

Foerfarande foer framstaellning av den nya farmaceutiskt anvaendbara hoegerroterande isomeren av en asymmetriskt spiro-hydantoinfoerening Download PDF

Info

Publication number
FI62838C
FI62838C FI781613A FI781613A FI62838C FI 62838 C FI62838 C FI 62838C FI 781613 A FI781613 A FI 781613A FI 781613 A FI781613 A FI 781613A FI 62838 C FI62838 C FI 62838C
Authority
FI
Finland
Prior art keywords
spiro
dione
fluoro
isomer
compound
Prior art date
Application number
FI781613A
Other languages
English (en)
Finnish (fi)
Other versions
FI62838B (fi
FI781613A (fi
Inventor
Reinhard Sarges
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of FI781613A publication Critical patent/FI781613A/fi
Publication of FI62838B publication Critical patent/FI62838B/fi
Application granted granted Critical
Publication of FI62838C publication Critical patent/FI62838C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10—Spiro-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/10—Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
FI781613A 1977-05-23 1978-05-22 Foerfarande foer framstaellning av den nya farmaceutiskt anvaendbara hoegerroterande isomeren av en asymmetriskt spiro-hydantoinfoerening FI62838C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US05/799,586 US4130714A (en) 1977-05-23 1977-05-23 Hydantoin therapeutic agents
US79958677 1977-05-23

Publications (3)

Publication Number Publication Date
FI781613A FI781613A (fi) 1978-11-24
FI62838B FI62838B (fi) 1982-11-30
FI62838C true FI62838C (fi) 1983-03-10

Family

ID=25176274

Family Applications (1)

Application Number Title Priority Date Filing Date
FI781613A FI62838C (fi) 1977-05-23 1978-05-22 Foerfarande foer framstaellning av den nya farmaceutiskt anvaendbara hoegerroterande isomeren av en asymmetriskt spiro-hydantoinfoerening

Country Status (37)

Country Link
US (1) US4130714A (de)
JP (1) JPS6035350B2 (de)
AR (1) AR219531A1 (de)
AT (1) AT357170B (de)
AU (1) AU499518B1 (de)
BE (1) BE867248A (de)
CA (1) CA1088073A (de)
CH (1) CH631455A5 (de)
CS (1) CS200550B2 (de)
DD (1) DD137107A5 (de)
DE (2) DE2858042C2 (de)
DK (1) DK147941C (de)
EG (1) EG13691A (de)
ES (1) ES470070A1 (de)
FI (1) FI62838C (de)
FR (1) FR2392024A1 (de)
GB (1) GB1572688A (de)
GR (1) GR68694B (de)
HK (1) HK53981A (de)
HU (1) HU177718B (de)
IE (1) IE47273B1 (de)
IL (1) IL54754A (de)
IN (1) IN147854B (de)
IT (1) IT1096306B (de)
KE (1) KE3168A (de)
LU (1) LU79685A1 (de)
MY (1) MY8200156A (de)
NL (1) NL7804158A (de)
NO (1) NO150206C (de)
NZ (1) NZ187334A (de)
PH (1) PH13828A (de)
PL (1) PL110460B1 (de)
PT (1) PT68071B (de)
SE (1) SE437375B (de)
SU (1) SU873885A3 (de)
YU (1) YU40829B (de)
ZA (1) ZA782919B (de)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11608323B2 (en) * 2013-10-07 2023-03-21 Syngenta Participations Ag Herbicidal compounds

Families Citing this family (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1088945A (en) * 1976-10-18 1980-11-04 Pfizer Limited Hydantoin derivatives as therapeutic agents
US4181728A (en) * 1978-11-16 1980-01-01 Pfizer Inc. Spiro-polycyclicimidazolidinedione derivatives
US4181729A (en) * 1979-03-21 1980-01-01 Pfizer Inc. Phenyl or phenoxy substituted spiro-imidazolidinedione derivatives
US4210667A (en) * 1979-04-19 1980-07-01 Pfizer Inc. Pharmaceutical preparations containing coumarin carboxylic acid derivatives
IE50332B1 (en) * 1979-11-13 1986-04-02 Ici Ltd 1'-substituted-spiro(imidazolidine-4,3'-indoline)-2,2',5-triones,processes for their manufacture and pharmaceutical compositions thereof
US4248882A (en) * 1980-02-12 1981-02-03 Pfizer Inc. Treating diabetes-associated complications with hydantoin amines
US4286098A (en) * 1980-03-28 1981-08-25 Pfizer Inc. Process for the preparation of chiral hydantoins
JPS5745185A (en) * 1980-07-21 1982-03-13 Eisai Co Ltd Hydantoin derivative and its preparation
US4419521A (en) * 1981-11-12 1983-12-06 Pfizer Inc. 6-Halo-4-chromanamines useful as intermediates to make chiral hydantoins
JPS58124788A (ja) * 1982-01-20 1983-07-25 Eisai Co Ltd 光学活性ヒダントイン誘導体，その製造方法ならびにそれを含有する治療用薬剤
US4464385A (en) * 1982-04-15 1984-08-07 Alcon Laboratories, Inc. Treatment of diabetic complications with hydantoins
US4540700A (en) * 1982-04-15 1985-09-10 Alcon Laboratories, Inc. Treatment of diabetic complications with certain spiro-imidazolidine-diones
US4438272A (en) 1982-04-15 1984-03-20 Alcon Laboratories, Inc. Spiro-(fluoren-9,4'-imidazolidine)-2',5'-diones
US4436745A (en) 1982-04-15 1984-03-13 Alcon Laboratories, Inc. Method of inhibiting aldose reductase activity
US4431828A (en) * 1982-11-10 1984-02-14 Pfizer Inc. Regeneration of 6-fluoro-4-chromanone from by-products in the synthesis of sorbinil
US4528387A (en) * 1982-11-10 1985-07-09 Pfizer Inc. Sorbinil by optical resolution of precursor 6-fluoro-4-ureidochroman-4-carboxylic acid
US4556670A (en) * 1982-12-06 1985-12-03 Pfizer Inc. Spiro-3-hetero-azolones for treatment of diabetic complications
US4474967A (en) * 1983-04-27 1984-10-02 Pfizer Inc. 8-Deutero and 8-tritio-substituted derivatives of D-4S-6-fluoro-spiro-[chroman-4,4'-imidazolidine]-2',5'-dione
US5153211A (en) * 1983-09-14 1992-10-06 Alcon Laboratories, Inc. Spiro-tricyclicaromatic succinimide derivatives as inhibitors of aldose reductase
US4537892A (en) * 1983-09-14 1985-08-27 Alcon Laboratories, Inc. Spiro-tricyclicaromatic succinimide derivatives as inhibitors of aldose reductase
EP0159143B1 (de) * 1984-03-23 1987-12-16 Pfizer Inc. Spiro-Indene und Spiro-1,2-Dihydro-Naphthalene für die Behandlung von diabetischen Komplikationen
US4717725A (en) * 1984-04-11 1988-01-05 Alcon Laboratories, Inc. Ophthalmic wound healing with aldose reductase inhibitors
US4600717A (en) * 1984-04-11 1986-07-15 Alcon Laboratories, Inc. Aldose reductase inhibitors useful in ophthalmic wound healing
JPH06772B2 (ja) * 1984-07-09 1994-01-05 鐘淵化学工業株式会社 ３―（４―フルオロフエノキシ）プロピオニトリルを用いる６―フルオロ―４―クロマノンの製造法
WO1986000807A1 (en) * 1984-07-20 1986-02-13 Pfizer Inc. Spiro-imidazolones for treatment of diabetes complications
US4656169A (en) * 1984-08-14 1987-04-07 Pfizer Inc. Tetracyclic spiro-hydantoin aldose reductase inhibitors and compositions
ATE37371T1 (de) * 1984-08-20 1988-10-15 Pfizer Verfahren zur herstellung asymmetrischer hydantoine.
US4620019A (en) * 1984-08-23 1986-10-28 Pfizer Inc. S-6-fluoro-4-aminochroman-4-carboxylic acid derivatives useful as intermediates for sorbinil
US4609663A (en) * 1984-09-11 1986-09-02 Alcon Laboratories, Inc. Aldose reductase inhibitors useful in glaucoma therapy
US4551542A (en) * 1984-09-26 1985-11-05 Pfizer Inc. Regeneration of 6-fluoro-4-chromanone from 6-fluoro-4-ureidochroman-4-carboxylic acid
US5340829A (en) * 1984-11-20 1994-08-23 Washington Research Foundation Immunoregulatory agents
US4966911A (en) * 1984-11-20 1990-10-30 Washington Research Foundation Immunoregulatory agents
JPS61200991A (ja) * 1985-03-04 1986-09-05 Sanwa Kagaku Kenkyusho:Kk スピロ―３―ヘテロアゾリジン化合物、その製法及びそれを有効成分とする糖尿病合併症の予防及び治療剤
WO1986007353A1 (en) 1985-06-14 1986-12-18 Pfizer Inc. Intermediate in the production of an asymmetric hydantoin
JPS627654U (de) * 1985-06-26 1987-01-17
WO1987004344A1 (en) * 1986-01-17 1987-07-30 Pfizer Inc. Hydroxyacetic acid derivatives for the treatment of diabetic complications
JPS6357588A (ja) * 1986-08-28 1988-03-12 Sanwa Kagaku Kenkyusho Co Ltd ヒダントイン誘導体、その塩並びに該化合物を有効成分とする糖尿病合併症の予防及び治療剤
CA1310269C (en) * 1987-03-20 1992-11-17 Billie M. York, Jr. Use of aldose reductase inhibitors to enhance insulin sensitivity in diabetes mellitus
US4841079A (en) * 1987-08-07 1989-06-20 Pfizer, Inc. Process for the production of asymmetric hydantoins
US4952694A (en) * 1988-07-27 1990-08-28 Pfizer Inc. Novel resolution process for racemic spiro-hydantoins
US5006657A (en) * 1988-07-27 1991-04-09 Pfizer Inc. Intermediates in a resolution process for racemic spiro hydantoins
AU617541B2 (en) * 1988-10-20 1991-11-28 Wyeth Spiro-isoquinoline-pyrrolidine tetrones and analogs thereof useful as aldose reductase inhibitors
JPH05508386A (ja) * 1989-02-10 1993-11-25 ワシントン　リサーチ　ファンデション 免疫調整剤
US4980357A (en) * 1990-03-01 1990-12-25 Pfizer Inc. Azolidinedione derivatives
US5039672A (en) * 1990-04-05 1991-08-13 Pfizer Inc. Heterocyclic compounds as aldose reductase inhibitors
US5236945A (en) * 1990-06-11 1993-08-17 Pfizer Inc. 1H-indazole-3-acetic acids as aldose reductase inhibitors
US5206367A (en) * 1992-02-18 1993-04-27 Pfizer Inc. Preparation of optically active spiro-hydantoins
WO1994007867A1 (en) * 1992-09-28 1994-04-14 Pfizer Inc. Substituted pyrimidines for control of diabetic complications
US5521208A (en) * 1993-07-29 1996-05-28 Alcon Laboratories, Inc. Compositions and methods for the treatment of the metabolically impaired and for improved compliance
KR100891756B1 (ko) * 1997-04-15 2009-04-07 씨에스아이알 식욕 억제 활성을 갖는 약학 조성물
GB2396815B (en) * 1999-10-27 2004-09-08 Phytopharm Plc A composition comprising a pregnenone derivative and an NSAID
GB2363985B (en) * 2000-06-30 2004-09-29 Phytopharm Plc Extracts,compounds & pharmaceutical compositions having anti-diabetic activity and their use
IL155710A0 (en) 2000-11-30 2003-11-23 Pfizer Prod Inc Combination of gaba agonists and aldose reductase inhibitors
US20110092566A1 (en) * 2004-11-19 2011-04-21 Srivastava Satish K Treatment of cancer with aldose reductase inhibitors
US8158667B2 (en) 2006-08-21 2012-04-17 Kador Peter F Topical treatment of cataracts in dogs
ATE518544T1 (de) 2007-03-12 2011-08-15 Zadec Aps Rotbusch-extrakt gegen diabetes
WO2008118844A1 (en) 2007-03-23 2008-10-02 The Board Of Regents Of The University Of Texas System Methods involving aldose reductase inhibitors
US20090270490A1 (en) * 2008-04-24 2009-10-29 The Board Of Regents Of The University Of Texas System Methods involving aldose reductase inhibition
CA2822672C (en) 2010-12-23 2018-06-05 The Board Of Regents Of The University Of Texas System Methods for treating copd

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2683718A (en) * 1952-01-11 1954-07-13 Searle & Co Spiro-[xanthene-9, 4'-imidazolidine]-2, 5-dione
DE1135915B (de) * 1961-06-29 1962-09-06 Asta Werke Ag Chem Fab Verfahren zur Herstellung neuer, antikonvulsiv wirksamer Spirohydantoine
CA1088945A (en) * 1976-10-18 1980-11-04 Pfizer Limited Hydantoin derivatives as therapeutic agents

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11608323B2 (en) * 2013-10-07 2023-03-21 Syngenta Participations Ag Herbicidal compounds

Also Published As

Publication number Publication date
ATA365378A (de) 1979-11-15
NO150206C (no) 1984-09-05
BE867248A (fr) 1978-11-20
PT68071A (en) 1978-06-01
DD137107A5 (de) 1979-08-15
SE7803626L (sv) 1978-11-24
AU499518B1 (en) 1979-04-26
HU177718B (en) 1981-12-28
FI62838B (fi) 1982-11-30
AT357170B (de) 1980-06-25
DE2821966A1 (de) 1978-11-30
DK147941B (da) 1985-01-14
LU79685A1 (fr) 1979-12-06
FI781613A (fi) 1978-11-24
DK147941C (da) 1985-08-26
ES470070A1 (es) 1979-01-01
NO781769L (no) 1978-11-24
IN147854B (de) 1980-07-19
NZ187334A (en) 1984-04-27
MY8200156A (en) 1982-12-31
PH13828A (en) 1980-10-07
DK226778A (da) 1978-11-24
GB1572688A (en) 1980-07-30
SU873885A3 (ru) 1981-10-15
HK53981A (en) 1981-11-13
EG13691A (en) 1982-12-31
AR219531A1 (es) 1980-08-29
DE2858042C2 (de) 1983-11-24
KE3168A (en) 1981-11-06
FR2392024A1 (fr) 1978-12-22
CS200550B2 (en) 1980-09-15
JPS6035350B2 (ja) 1985-08-14
IT1096306B (it) 1985-08-26
US4130714A (en) 1978-12-19
PT68071B (en) 1979-10-26
CH631455A5 (fr) 1982-08-13
SE437375B (sv) 1985-02-25
IL54754A (en) 1982-04-30
IL54754A0 (en) 1978-07-31
CA1088073A (en) 1980-10-21
JPS53144575A (en) 1978-12-15
PL110460B1 (en) 1980-07-31
NL7804158A (nl) 1978-11-27
IE47273B1 (en) 1984-02-08
IT7823672A0 (it) 1978-05-22
YU40829B (en) 1986-06-30
DE2821966C2 (de) 1983-06-01
FR2392024B1 (de) 1981-07-24
ZA782919B (en) 1979-06-27
IE781015L (en) 1978-11-23
GR68694B (de) 1982-02-01
YU116978A (en) 1983-02-28
PL206826A1 (pl) 1979-04-23
NO150206B (no) 1984-05-28

Similar Documents

Publication Publication Date Title
FI62838C (fi) Foerfarande foer framstaellning av den nya farmaceutiskt anvaendbara hoegerroterande isomeren av en asymmetriskt spiro-hydantoinfoerening
EP0193415B1 (de) Spiro-3-heteroazolidinverbindungen und ihre Salze, ihre Herstellung und diese enthaltende pharmazeutische Mittel
SU820659A3 (ru) Способ получени производных 4-амино- 5-АлКилСульфОНилОАНизАМидОВ, иХ СОлЕй,ОКиСЕй, лЕВО- и пРАВОВРАщАющиХизОМЕРОВ /иХ ВАРиАНТы/
CS199690B2 (cs) Způsob výroby spiro-hydantoinových derivátů
EP0264586B1 (de) Hydantoin-Derivate zur Behandlung von Komplikationen bei Diabetes
EP0017379B1 (de) Phenyl- oder Phenoxy-substituierte Spiro-imidazolidindion-Derivate, deren pharmazeutische Zusammensetzungen und Verfahren zu ihrer Herstellung
IE47726B1 (en) Thienohydantoin derivatives
PL94252B1 (en) 1-Oxo-2,2-disubstituted-5-indanyloxy(or thio)alkanoic acids[US3984465A]
JPS6052157B2 (ja) スピロ−多環式イミダゾリジンジオン誘導体
US4134991A (en) Derivatives of 2-(3-phenyl-2-aminopropionyloxy)-acetic acid
SU1710558A1 (ru) Замещенные 1Н-имидазолы, про вл ющие антиишемическую активность
FR2633619A1 (fr) Nouveau sel de strontium, son procede de preparation et les compositions pharmaceutiques le renfermant
FR2552433A1 (fr) Nouveaux derives de 1,3,4-thiadiazole, procede pour leur preparation et leur utilisation comme agents anti-ulcere
US4177282A (en) Hydantoin therapeutic agents
EP0092386B1 (de) Hydantoin enthaltende therapeutische Mittel
KR870000584B1 (ko) 6-플루오로-4-우레이도크로만-4-카복실산으로부터 6-플루오로-4-크로만온의 재생방법
EP0026289B1 (de) Antihypertensive Polyhalohydroxyisopropylphenylalkan- und -alkensäuren, deren Amide und Ester, pharmazeutische Mischungen daraus und Zwischenprodukte hierzu
EP0168181A1 (de) Zyklische Amide
EP0112620B1 (de) 5-(Substituierte Phenyl)-Hydantoine
FI77235B (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara spiro-polycykliska imidazolidindionderivat.
KR820001306B1 (ko) 스피로-히단토인 화합물의 제조방법
US5508280A (en) 5H-Dibenzo (A,D) cycloheptenes as muscarinic receptor antagonists
FI63579B (fi) Foerfarande foer framstaellning av en ny terapeutiskt anvaendbar spiro-benso(b)tiofen(3,4')imidazolidin-2,5-dion-1,1-dioxid
WO1999051577A1 (de) (s)-2-(biphenyl-4-sulfonylamino)-3-(1h-indolyl)-propionsäurederivate als matrix-metalloproteinasehemmer
PL115960B1 (en) Method of manufacture of novel derivatives of phthalazine-4-ylacetic acid

Legal Events

Date Code Title Description
MM Patent lapsed
MM Patent lapsed

Owner name: PFIZER INC.